Helicobacter Pylori Infection and Upper Gastrointestinal Disease

Open access

Helicobacter Pylori Infection and Upper Gastrointestinal Disease

Helicobacter pylori infection is one of the most common bacterial infections in humans, being present in over a half of the world population. Helicobacter pylori infection, by itself, does not necessarily produce the symptoms of gastrointestinal tract diseases, but certainly presents a risk for their development. The clinical outcome of Helicobacter pylori infection depends on the interaction of numerous factors: the virulence of a bacterial strain, genetic predisposition and premorbid host conditions, as well as the environmental factors. Accordingly, a diagnosis of Helicobacter pylori infection will be of clinical relevance only if it is necessary to establish the cause of a disease associated with this infection. Thus, a thorough knowledge of the diseases associated with Helicobacter pylori infection is a key factor in any relevant assessment of the need for eradication therapy.

Bizzozero G. Ueber die schlauchformigen drusen des magendarmkanals und die bezienhungen ihres epithels zu dem oberflachenepithel der schleimhaut. Arch Mikr Anat 1893;42:82.

Marschall BJ, Warren JR. Unindentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-5.

Goodwin CS, Armstrong JA, Chilvers T, Peters M, Colins MD, Sly L, McConnell W, Harper WES. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int J Syst Bacteriol 1989;39:397-405. http://dx.doi.org/10.1099/00207713-39-4-397

Morris AJ, Ali MR, Nicholson GI, Perez-Perez GI, Blaser MJ. Long-term follow-up of voluntary ingestion of Helicobacter pylori. Ann Intern Med 1991;114:662-663. PMid:2003713

Graham DY, Malaty HM, Evans DG, Evans DJ, Jr, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991;100(6):1495-1501. PMid:2019355

Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995;9 Suppl 2:33-39.

Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ, Heatley RV, Axon ATR. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991;32:1415-8. http://dx.doi.org/10.1136/gut.32.11.1415PMid:1752479 PMid:1752479 PMCid:1379180

Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori - infected subjects. Infec. Immun 1998;66:5964-71. PMid:9826379 PMCid:108755

Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol. 2000;54:615-40. http://dx.doi.org/10.1146/annurev.micro.54.1.615 PMid:11018139

Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999;13:3-12. http://dx.doi.org/10.1046/j.1365-2036.1999.00002.x PMid:10209681

Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9(Suppl. 2):59-69. PMid:8547530

Censini S, Lange C, Xiang Z, Crabtree J E, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53. http://dx.doi.org/10.1073/pnas.93.25.14648

Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-500. http://dx.doi.org/10.1126/science.287.5457.1497 PMid:10688800

Monack DM, Mueller A, Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol 2004;747-65. http://dx.doi.org/10.1038/nrmicro955 PMid:15372085

Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Memet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5:1166-74. http://dx.doi.org/10.1038/ni1131 PMid:15489856

Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995; 87:1777-80. http://dx.doi.org/10.1093/jnci/87.23.1777

Blaser MJ, Crabtree JE. CagA and the outcome of Helicobacter pylori infection. Am. J Clin Pathol 1996; 106:565-7. PMid:8929462

Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997;112:92-9. http://dx.doi.org/10.1016/S0016-5085(97)70223-3

Montecucco C, de Bernard M. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect. 2003; 5:715-21. http://dx.doi.org/10.1016/S1286-4579(03)00124-2

Zhang QB, Etolhi G, Dawodu JB, Husain A, Gemmell CG, Russell RI. Relationship between mucosal levels of interleukin 8 and toxinogenicity of Helicobacter pylori. Inflammopharmacology 1998; 6(2):109-17. http://dx.doi.org/10.1007/s10787-998-0028-y PMid:17694368

Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 2003;63:951-7. PMid:12615708

Neu B, Randlkofer P, Neuhofer M, Voland P, Mayerhofer A, Gerhard M, Schepp W, Prinz C. Helicobacter pylori induces apoptosis of rat gastric parietal cells. Am. J. Physiol. Gastrointest. Liver Physiol 2002; 283: 309-G318.

Atherton JC, Cao P, Peek RM Jr, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270:17771-7. PMid:7629077

Molinari M, Salio M, Galli C, Norais N, Rappuoli R, Lanzavecchia A, Montecucco C. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA J Exp Med 1998; 187:135-140. http://dx.doi.org/10.1084/jem.187.1.135 PMid:9419220 PMCid:2199184

Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999;37:2274-9. PMid:10364597 PMCid:85136

Smoot DT, Mobley HL, Chippendale GR, Lewison, JF, Resau JH. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 1990; 58: 1992-4. PMid:2341188 PMCid:258755

Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999; 96:12778-83. http://dx.doi.org/10.1073/pnas.96.22.12778

Yamaoka Y, Souchek J, Odenbreit S, Haas R, Arnqvist A, Borén T, Kodama T, Osato MS, Gutierrez O, Kim JG, Graham DY. Discrimination between Cases of Duodenal Ulcer and Gastritis on the Basis of Putative Virulence Factors of Helicobacter pylori. J Clin Microbiol 2002;40(6):2244-6. http://dx.doi.org/10.1128/JCM.40.6.2244-2246.2002 PMid:12037098 PMCid:130665

Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006;55:775-1. http://dx.doi.org/10.1136/gut.2005.083014 PMid:16322107 PMCid:1856239

Robinson K, Argent RH, Atheron JC. The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007;21(2):237-59. http://dx.doi.org/10.1016/j.bpg.2007.01.001

Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5. http://dx.doi.org/10.1016/0140-6736(92)90929-W

Dinić M, Tasić G, Stanković Đorđević D, Otašević Lj, Tasić M, Karanikolić A. Serum anti-Helicobacter pylori IgA and IgG antibodies in asymptomatic children in Serbia. Scand J Infect Dis 2007;39:303-7. http://dx.doi.org/10.1080/00365540601034741PMid:17454893

Otašević M, Dinić M, Miljković Selimović B, Otašević Lj, Stojanović P. Mikrobiološka dijagnoza Helicobacter pylori infekcije. Acta Fac Med Naiss 2003;20(1):22-8.

Ibraghimov A, Pappo J. The immune response against Helicobacter pylori - a direct linkage to the development of gastroduodenal disease. Microbes and Infection 2000;1073-7. http://dx.doi.org/10.1016/S1286-4579(00)01261-2

Kim SS, Ruiz VE, Carroll JD, Moss SF. Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Letters 2011;305:228-38. http://dx.doi.org/10.1016/j.canlet.2010.07.014 PMid:20692762

Blaser MJ, Atherton JC. Helicobacter pylori: biology and disease. J Clin Invest 2004;113:321-33. PMid:14755326 PMCid:324548

Kuipers EJ. Review article: relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1998;12:25-36. http://dx.doi.org/10.1111/j.1365-2036.1998.00009.x PMid:9701002

International Agency for Research on Cancer. 1994. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 61: schistosomes, liver flukes and Helicobacter pylori. International Agency for Research on Cancer, Lyon, France.

Otašević M, Nagorni A, Stanković Đorđević D, Dinić M, Otašević Lj. Helicobacter pylori and gastric cancer. Archive of Oncology 2003;11(4):233-7. http://dx.doi.org/10.2298/AOO0304233O

Lai LH, Sung JJ. Helicobacter pylori and benign upper digestive disease. Best Pract Res Clin Gastroenterol 2007;21(2):261-79. http://dx.doi.org/10.1016/j.bpg.2006.10.002

Acta Facultatis Medicae Naissensis

The Journal of Faculty of Medicine in Nis

Journal Information


Cite Score 2018: 0.33

SCImago Journal Rank (SJR) 2018: 0.134
Source Normalized Impact per Paper (SNIP) 2018: 0.287

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 237 173 10
PDF Downloads 80 67 4